Atlas Trials

Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia

Clinical trial NCT00754221 · TERMINATED

Trial details

NCT number
NCT00754221
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Fibromyalgia
Start date
2008-05-01
Primary completion
2009-05-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.